drugset / Trial / NCT05137522
Chidamide Combines With VP-16 and Methylprednisolone in the Treatment of HLH
NaSingle-groupOpen-labelTreatment
Summary
Chidamide combines with VP-16 and methylprednisolone in HLH
Timeline
- Start
- 2021-07-01
- Primary completion
- 2023-07-01
- Completion
- 2023-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tucidinostat | Small molecule | 30 mg | Oral |
| Background | Etoposide | Small molecule | 100 mg/m2 | — |
| Background | Methylprednisolone | Other / unclassified | 0.1 mg/kg | — |